PHARMALOGICAL Trademark

Trademark Overview

On Thursday, May 13, 2021, a trademark application was filed for PHARMALOGICAL with the United States Patent and Trademark Office. The USPTO has given the PHARMALOGICAL trademark a serial number of 90710593. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, March 15, 2024. This trademark is owned by Epsilon Molecular Engineering Incorporated. The PHARMALOGICAL trademark is filed in the Advertising, Business and Retail Services category with the following description:

Compilation and systematization of information in DNA sequence databanks
pharmalogical

General Information

Serial Number90710593
Word MarkPHARMALOGICAL
Filing DateThursday, May 13, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, March 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements

Pseudo MarkPHARMA LOGICAL
Goods and ServicesCompilation and systematization of information in DNA sequence databanks

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code035
First Use Anywhere DateMonday, October 25, 2021
First Use In Commerce DateMonday, May 2, 2022

Trademark Owner History

Party NameEpsilon Molecular Engineering Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaitama City, Saitama 338-8570
JP
Party NameEpsilon Molecular Engineering Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaitama city, Saitama 338-0824
JP

Trademark Events

Event DateEvent Description
Saturday, March 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 30, 2023USE AMENDMENT FILED
Wednesday, August 30, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, April 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 3, 2023SOU EXTENSION 1 GRANTED
Monday, April 3, 2023SOU EXTENSION 1 FILED
Monday, April 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023CORRECTED NOA E-MAILED
Thursday, March 2, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, February 7, 2023DIVISIONAL REQUEST RECEIVED
Thursday, March 2, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 27, 2023ASSIGNED TO PETITION STAFF
Tuesday, February 7, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 19, 2022REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, September 13, 2022ASSIGNED TO PETITION STAFF
Friday, August 26, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 4, 2022NON-FINAL ACTION E-MAILED
Monday, April 4, 2022NON-FINAL ACTION WRITTEN
Thursday, January 20, 2022ASSIGNED TO EXAMINER
Thursday, August 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 17, 2021NEW APPLICATION ENTERED

Related Keywords

pharmalogical databanks sequence information systematization compilation